4//SEC Filing
Baeuerle Patrick 4
Accession 0000899243-19-030063
CIK 0001750019other
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 5:30 PM ET
Size
7.8 KB
Accession
0000899243-19-030063
Insider Transaction Report
Form 4
Baeuerle Patrick
Director
Transactions
- Sale
Common Stock
2019-12-23$15.44/sh−84,907$1,310,964→ 350,786 total(indirect: By APAK Solutions GmbH) - Sale
Common Stock
2019-12-20$15.16/sh−32,022$485,454→ 435,693 total(indirect: By APAK Solutions GmbH)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- [F2]$15.16 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The reported securities are owned directly by APAK Solutions GmbH. The Reporting Person is managing director of APAK Solutions GmbH. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
- [F4]$15.44 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.01 to $16.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
TCR2 THERAPEUTICS INC.
CIK 0001750019
Entity typeother
Related Parties
1- filerCIK 0001362054
Filing Metadata
- Form type
- 4
- Filed
- Dec 25, 7:00 PM ET
- Accepted
- Dec 26, 5:30 PM ET
- Size
- 7.8 KB